Cargando…

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway

PURPOSE: By using integrative RNA sequencing analysis, we identified a novel tumor suppressor, serpin family A member 11 (SERPINA11), which is a serine proteinase inhibitor that belongs to the serpin superfamily. However, the function of SERPINA11 in hepatocellular carcinoma (HCC) remains unclear. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ye, Li, Zhuo, Li, Lei, Zhou, Houming, Zeng, Ting-Ting, Jin, Chuan, Lin, Jin-Rong, Gao, Sha, Li, Yan, Guan, Xin-Yuan, Zhu, Ying-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275163/ https://www.ncbi.nlm.nih.gov/pubmed/34268259 http://dx.doi.org/10.2147/JHC.S315634

Ejemplares similares

RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma
por: Zhou, Jie, et al.
Publicado: (2023)

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
por: Zhang, Ying, et al.
Publicado: (2022)

CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2022)

Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9
por: Hsieh, Min-Hong, et al.
Publicado: (2019)

Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK–ERK Pathway
por: Lu, Ko-Hsiu, et al.
Publicado: (2021)

Correction: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2023)

LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
por: Chen, Ziye, et al.
Publicado: (2021)

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway
por: Wang, Fang, et al.
Publicado: (2023)

RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma
por: Bai, Xue-Song, et al.
Publicado: (2020)

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
por: Li, Qingfang, et al.
Publicado: (2022)

Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer
por: An, Xi-Zhou, et al.
Publicado: (2016)

Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway
por: Kochetkova, Elena Y., et al.
Publicado: (2017)

MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression
por: Farnsworth, Dylan A., et al.
Publicado: (2022)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
por: Yuan, Qing, et al.
Publicado: (2021)

Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal
por: Fang, Weilin, et al.
Publicado: (2023)

SERPINA2 Is a Novel Gene with a Divergent Function from SERPINA1
por: Marques, Patrícia Isabel, et al.
Publicado: (2013)

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence
por: Liu, Mingyu, et al.
Publicado: (2018)

MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways
por: Zhang, Ruitao, et al.
Publicado: (2019)

A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway
por: Sun, Jin, et al.
Publicado: (2023)

Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy
por: Wang, Huiqiang, et al.
Publicado: (2017)

S100A11 Promotes Metastasis via AKT and ERK Signaling Pathways and Has a Diagnostic Role in Hepatocellular Carcinoma
por: Zheng, Mei, et al.
Publicado: (2023)

Transcriptional Activation of Gstp1 by MEK/ERK Signaling Confers Chemo-Resistance to Cisplatin in Lung Cancer Stem Cells
por: Li, Jingyuan, et al.
Publicado: (2019)

DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways
por: Yin, Xiaoran, et al.
Publicado: (2014)

Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis
por: Shao, Guo-Li, et al.
Publicado: (2018)

Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway
por: Wu, Dongdong, et al.
Publicado: (2019)

Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration
por: Li, Ju-Pi, et al.
Publicado: (2022)

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
por: Zhao, Xuetao, et al.
Publicado: (2018)

Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma
por: ZHANG, ZHI, et al.
Publicado: (2016)

BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma
por: Liu, Fen, et al.
Publicado: (2017)

Overexpression of SERPINA3 suppresses tumor progression by modulating SPOP/NF-κB in lung cancer
por: Jin, Yanxia, et al.
Publicado: (2023)

Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats
por: Li, Zhi-Yuan, et al.
Publicado: (2017)

Integrative Genomic Analysis Identifies That SERPINA6-rs1998056 Regulated by FOXA/ERα Is Associated with Female Hepatocellular Carcinoma
por: Shen, Na, et al.
Publicado: (2014)

The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease
por: Li, Bo, et al.
Publicado: (2021)

STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling
por: Wang, Zhaowen, et al.
Publicado: (2016)

Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model
por: Chen, John Chun-Hao, et al.
Publicado: (2016)

Porcine deltacoronavirus activates the Raf/MEK/ERK pathway to promote its replication
por: Jeon, Ji Hyun, et al.
Publicado: (2020)

SERPINA3 in glioblastoma and Alzheimer’s disease
por: Norton, Emily S., et al.
Publicado: (2021)

The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
por: Wang, Zeyou, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k4spu58sa4bhhsc5km46mersk5